Drug Shortage Report for ADVAIR
| Report ID | 166414 |
| Drug Identification Number | 02245127 |
| Brand name | ADVAIR 250 |
| Common or Proper name | fluticasone propionate and salmeterol pressurised inhalation, suspension |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | FLUTICASONE PROPIONATE SALMETEROL |
| Strength(s) | 250MCG 25MCG |
| Dosage form(s) | AEROSOL, METERED DOSE |
| Route of administration | INHALATION INHALATION |
| Packaging size | 1x120 |
| ATC code | R03AK |
| ATC description | ADRENERGICS, INHALANTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2022-08-05 |
| Estimated end date | 2022-08-31 |
| Actual end date | 2022-08-30 |
| Shortage status | Resolved |
| Updated date | 2022-08-31 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2022-08-31 | French | Compare |
| v7 | 2022-08-31 | English | Compare |
| v6 | 2022-08-24 | French | Compare |
| v5 | 2022-08-24 | English | Compare |
| v4 | 2022-08-17 | French | Compare |
| v3 | 2022-08-17 | English | Compare |
| v2 | 2022-08-10 | French | Compare |
| v1 | 2022-08-10 | English | Compare |
Showing 1 to 8 of 8